On October 7, 2024, the Supreme Court declined to hear Cellect LLC v. Vidal, No. 23-1231. The case has been followed closely by patent professionals ever since the Federal Circuit upended the judicially-created doctrine of...more
In December 2021, patent practice was upended by four related United States Patent and Trademark Office (USPTO) Patent Trial & Appeal Board (PTAB) decisions holding that patents subject to statutory Patent Term Adjustment...more
What Congress has guaranteed, the courts have taken away -
The Supreme Court is about to receive a Petition for Certiorari in a case that impacts how long a patent protects new inventions, we expect. Specifically, the case...more
5/16/2024
/ Food and Drug Administration (FDA) ,
Hatch-Waxman ,
Inventions ,
Obviousness-Type Double Patenting (ODP) ,
Patent Term Adjustment ,
Patent Trial and Appeal Board ,
Patents ,
Petition for Writ of Certiorari ,
Popular ,
SCOTUS ,
USPTO
As of June 2024, Milan will begin hearing cases regarding patents classified in IPC Section (A), which includes pharmaceuticals.
Milan will have competence to hear revocation actions, as well as actions for declaration of...more
The Climate Change Mitigation Pilot Program offers an opportunity for companies in the climate space to cheaply expedite the examination of US patent applications.
The grant of a US patent provides a strong signal to...more